Relief Therapeutics Holding AG Share Price Other OTC
Equities
RLFTF
CH0100191136
Biotechnology & Medical Research
Sales 2022 | 60.81L 66.87L 56Cr | Sales 2023 | 60.33L 66.34L 55Cr | Capitalization | 2.5Cr 2.74Cr 228.66Cr |
---|---|---|---|---|---|
Net income 2022 | -5Cr -5.5Cr -458.13Cr | Net income 2023 | -9.8Cr -11Cr -897.94Cr | EV / Sales 2022 | 19.3 x |
Net cash position 2022 | 1.49Cr 1.64Cr 136.46Cr | Net cash position 2023 | 1.03Cr 1.13Cr 94Cr | EV / Sales 2023 | 2.44 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
-0.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.87% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | 55 | 28/22/28 |
Ram Selvaraju
CHM | Chairman | 45 | 25/16/25 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 25/16/25 |
Paolo Galfetti
PRN | Corporate Officer/Principal | 59 | 27/21/27 |
Michelle Lock
CEO | Chief Executive Officer | 55 | 28/22/28 |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 5.09TCr | |
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr |